22q11.2 Deletion Syndrome Clinical Trials

14 clinical trials for 22q11.2 Deletion Syndrome across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome — RECRUITING
• The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment — RECRUITING
• Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders — RECRUITING
• Understanding of Psychotic Disorders in Children With 22q11.2DS — RECRUITING · NA
• Early Scoliotic Changes in Children at Increased Risk for Scoliosis Development — RECRUITING
• Open-Label Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With 22q11.2 Deletion Syndrome (INSPIRE) — COMPLETED · PHASE2
• Arithmetic Abilities in Children With 22q11.2DS — TERMINATED · NA
• Neuroprotective Effects of Risperdal on Brain and Cognition in 22q11 Deletion Syndrome — TERMINATED · NA
• Effects of Methylphenidate on Brain and Cognition in 22q11 Deletion Syndrome — COMPLETED · NA
• Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric Conditions — COMPLETED · PHASE1
• Genetic Modifiers for 22q11.2 Syndrome — COMPLETED
• Social Cognition Training and Cognitive Remediation — TERMINATED · NA
• Resolution of Primary Immune Defect in 22q11.2 Deletion Syndrome — COMPLETED
• Cognitive Remediation in 22q11DS — COMPLETED · NA

Refine this search